Effect of systemic L-arginine administration on hemodynamics and nitric oxide release in man

Jpn Heart J. 1992 Jan;33(1):41-8. doi: 10.1536/ihj.33.41.

Abstract

The effects of L-arginine administration on systemic hemodynamics and plasma concentrations of neuro-endocrine hormones and amino acids were investigated in 10 normotensive healthy volunteers. Nitrite/nitrate in urine and cyclic guanosine monophosphate (c-GMP) in plasma were also measured as indicators of release of nitric oxide (NO). L-arginine administration (30 g/300 ml/30 min) caused hypotension (mean arterial pressure; 79.3 +/- 3.9 mmHg fell to 68.8 +/- 2.2 mmHg) with tachycardia (62.3 +/- 2.3 beats/min increased to 67.5 +/- 1.9 beats/min). The plasma concentration of L-arginine before administration was 98.8 +/- 8.2 mumol/l and increased to 7263 +/- 567 mumol/l 20 min after administration. Cardiac output also increased to 127.2 +/- 3.9% by L-arginine administration. Total peripheral resistance was calculated to fall to 65.9 +/- 2.0%. L-arginine administration slightly changed several hormones, but all values were within normal ranges. Nitrite/nitrate in urine increased 142.1 +/- 12.4% compared to the values before L-arginine administration. Plasma concentrations of c-GMP and L-citrulline, the by-product of NO from L-arginine, were also significantly increased by L-arginine administration. All our results provide evidence for the first time that systemically administered L-arginine releases NO in man.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amino Acids / blood
  • Arginine / pharmacology*
  • Blood Pressure / drug effects
  • Cyclic GMP / blood
  • Heart Rate / drug effects
  • Hemodynamics / drug effects*
  • Hormones / blood
  • Humans
  • Male
  • Nitric Oxide / metabolism*
  • Nitrites / urine

Substances

  • Amino Acids
  • Hormones
  • Nitrites
  • Nitric Oxide
  • Arginine
  • Cyclic GMP